Vulnerability · CVE-2025-47458
Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') vulnerability in B2itech B2i Investor Tools b2i-investor-tools allows Reflected XSS.This issue
Published May 23, 2025 · catalog updated Apr 28, 2026 · B2itech B2i Investor Tools
Check if you run it
No confirmed exploitation is on record for CVE-2025-47458. EPSS is 0.27%. Act only if a listed version of B2itech B2i Investor Tools is installed.
Gaps on this record
- No vendor fix or required action is stored. Compare the linked advisory before you change production.
- Severity
- High7.1
- Known exploitation
- Not in CISA/VulnCheck KEV
- EPSS
- 0.27%
- Remediation
- Advisory link
- Affected products
- vendor B2itech B2i Investor Tools 0 ≤1.0.7.9
Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') vulnerability in B2itech B2i Investor Tools b2i-investor-tools allows Reflected XSS.This issue affects B2i Investor Tools: from n/a through <= 1.0.7.9.
Are you affected?
Enter the version you run. The result uses only the ranges stored on this record.
The check returns affected, not affected, or incomplete. It does not guess a version that is missing from the record.
- vendor B2itech B2i Investor Tools 0 ≤1.0.7.90 ≤1.0.7.9
How to fix CVE-2025-47458
Recommended remediation
A patch or advisory reference is linked. Open the original publisher for availability by product version.
Official advisories
What to do
Three questions, each answered from this record only. Confirm the vendor advisory before you patch.
Should you patch?
No confirmed exploitation is on record for CVE-2025-47458. EPSS is 0.27%. Act only if a listed version of B2itech B2i Investor Tools is installed.
Which versions are affected?
Compare what you have installed with B2itech B2i Investor Tools 0 ≤1.0.7.9 0 ≤1.0.7.9. Compare the installed version with the linked vendor advisory before you change production.
What should an analyst verify?
No weakness class is stored. EPSS 0.27%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.
Code
The project this record applies to. Exploit listings stay in References.
No public source repository is identified for this product.
Timeline
Detection, updates, and resolution for this record.
May 23, 2025 · EUVD
Detected
Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') vulnerability in B2itech B2i Investor Tools b2i-investor-tools allows Reflected XSS.This issue affects B2i Investor Tools: from n/a through <= 1.0.7.9.
Apr 28, 2026 · EUVD
Updated
Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') vulnerability in B2itech B2i Investor Tools b2i-investor-tools allows Reflected XSS.This issue affects B2i Investor Tools: from n/a through <= 1.0.7.9.
Sources
- CVE.orgVulnerability recordCVE-2025-47458
Official CVE identifier
cve.org - FIRST EPSSExploitation probabilityCVE-2025-47458
30-day exploitation probability 0.3%
first.org - EUVDVulnerability recordEUVD-2025-28084
Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') vulnerability in B2itech B2i Investor Tools b2i-investor-tools allows Reflected XSS.This issue affects B2i Investor Tools: from n/a through <= 1.0.7.9.
euvd.enisa.europa.eu
References
Freshness
Last verified in this catalog Oct 18, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.